https://www.thebodypro.com/category/hiv-epidemiology/tag/ias-international-aids-society-conference
HIV Epidemiology

IAS (International AIDS Society) Conference

The Latest

Steven Deeks, M.D.

The State of Cure Research for HIV and Hepatitis B: Similarities and Differences

Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.

Ivana Beesham

Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa

ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.

Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

What Are the Common HIV Transmission Pathways Among Trans Women? Img

What Are the Common HIV Transmission Pathways Among Trans Women?

Many trans women living with HIV may contract the virus because they or their sexual partners are intravenous drug users (IDU), finds a new study.

IAS and WHO Identify the Most Critical Research Needs for Infants, Children and Adolescents Living With HIV Img

IAS and WHO Identify the Most Critical Research Needs for Infants, Children and Adolescents Living With HIV

The most pressing gaps in research needed to improve outcomes for children and adolescents living with HIV are highlighted in the first global priority research agendas on paediatric and adolescent HIV.

Roy Gulick on the Evolution of HIV Treatment After 1996 (Video) Img

Roy Gulick on the Evolution of HIV Treatment After 1996 (Video)

Today, new classes of antiretrovirals, such as attachment inhibitors, continue to be developed, and synthetic versions of naturally occurring antibodies -- broadly neutralizing antibodies -- are being studied for both HIV treatment and prevention....

Julio Montaner on the Last 20 Years in HIV Research (Video) Img

Julio Montaner on the Last 20 Years in HIV Research (Video)

Looking back on how far we have come, Julio Montaner, M.D., director of the British Columbia Centre for Excellence in HIV/AIDS says we now have the "irrefutable, conclusive, impeccable" proof that starting HIV treatment immediately after testing posi...

Large Variation Across Countries in Meeting UNAIDS 90-90-90 Targets Img

Large Variation Across Countries in Meeting UNAIDS 90-90-90 Targets

Analysis of national treatment cascades showed huge variation in achieving UNAIDS 90-90-90 targets. The proportion of HIV positive people with undetectable viral load ranged from 68% in Switzerland to 9% in Russia. No country analysed met the UNAIDS ...

HIV Remission for More Than 12 Years After Very Early Treatment in French Teenager Img

HIV Remission for More Than 12 Years After Very Early Treatment in French Teenager

An 18-year-old female has been able to maintain an undetectable viral load for more than 12 years after interrupting early antiretroviral treatment, according to a study presented at IAS 2015.

Promo Image

New Global Update on HIV/AIDS Shows 9.7 Million on Treatment in 2012

A new report from UNAIDS, the WHO and UNICEF, titled "Global update on HIV treatment 2013: results, impact and opportunities" and released at the 7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Kuala L...